:: CLDF ::

Home | Contact Us | Bookmark

MASH

HCC

ALCOHOL LIVER DISEASE

PEDIATRIC LIVER DISEASE

Embassy of Education

Publications Webcasts Abstract Library Committee Members

MASH | Abstract Library

The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.

1.	Evaluating the Effectiveness of Pegbelfermin in MASH-Associated Hepatic Fibrosis A Meta-Analysis and Systematic Review of Randomized Controlled Trials.
	JGH Open.2025 Mar 17;9(3):e70131.doi:10.1002/jgh3.70131
	Shahzil, Muhammad (M);Hasan, Fariha (F);Kazmi, Syeda Kanza (SK);Gangwani, Manesh Kumar (MK);Shabbar, UmmeSalma (U);Chaudhary, Ammad Javaid (AJ);Khaqan, Muhammad Ali (MA);Faisal, Muhammad Saad (MS);Williams, Kathy N (KN);Mohan, Babu P (BP);Tofani, Christina (C);

2.	The prevalence of nonalcoholic fatty liver disease in people living with HIV: a systematic review and meta-analysis.
	BMC Infect Dis.2025 Feb 19;25(1):239.doi:10.1186/s12879-025-10455-y
	Wei, Jiaqi (J);Hui, Wei (W);Fang, Yuan (Y);Jia, Han (H);Yang, Yu (Y);Zhang, Tong (T);Wu, Hao (H);Su, Bin (B);Jiang, Taiyi (T);

3.	Biological age prediction and NAFLD risk assessment: a machine learning model based on a multicenter population in Nanchang, Jiangxi, China.
	BMC Gastroenterol.2025 Mar 13;25(1):172.doi:10.1186/s12876-025-03752-y
	Deng, Lianrui (L);Huang, Jing (J);Yuan, Hang (H);Liu, Qiangdong (Q);Lou, Weiming (W);Yu, Pengfei (P);Xie, Xiaohong (X);Chen, Xuyu (X);Yang, Yang (Y);Song, Li (L);Deng, Libin (L);

4.	Regional insights into the relationship between metabolic associated steatotic liver disease and chronic kidney disease: a socioeconomic perspective on disease correlation.
	BMC Public Health.2025 Mar 13;25(1):993.doi:10.1186/s12889-025-22188-3
	Bai, Jiang (J);Zhang, Lijuan (L);Zhang, Mingyan (M);Hao, Yifan (Y);Yi, Zhen (Z);Zhou, Yun (Y);

5.	Decreased intestinal abundance of is associated with metabolic disorders among people living with HIV.
	Ann Med.2025 Mar 07;57(1):2474730.doi:10.1080/07853890.2025.2474730
	Qian, Zhe (Z);Chen, Suling (S);Liao, Xiaoyang (X);Xie, Jingfang (J);Xu, Yuyuan (Y);Zhong, Huiqun (H);Ou, Lang (L);Zuo, Xiang (X);Xu, Xuwen (X);Peng, Jie (J);Wu, Jian (J);Cai, Shaohang (S);

6.	Comparison of efficacy and safety of pioglitazone and SGLT2 inhibitors in treating Asian patients in MASLD associated with type 2 diabetes: A meta-analysis.
	J Diabetes Complications.2025 Mar 03;39(4):108998.doi:10.1016/j.jdiacomp.2025.108998
	Liu, Lingyan (L);Deng, Yongkun (Y);Yang, Lijuan (L);Wang, Miaojiao (M);Lai, Yong (Y);

7.	Factors influencing mental health outcomes among university students: a cross-sectional study in Bangladesh.
	BMJ Open.2025 Mar 04;15(3):e097745.doi:10.1136/bmjopen-2024-097745
	Al-Amin, Md (M);Rinky, Farhana (F);Nizamul Hoque Bhuiyan, Md (M);Yeasmin, Roksana (R);Akter, Tasmia (T);Hoque, Nowrin (N);Reza, Sompa (S);

8.	Assessment of Positional Obstructive Sleep Apnea in Children Undergoing Adenotonsillectomy for Obstructive Sleep Apnea.
	Laryngoscope Investig Otolaryngol.2025 Mar 04;10(2):e70116.doi:10.1002/lio2.70116
	Ulualp, Seckin O (SO);Johnson, Romaine F (RF);Mitchell, Ron B (RB);

9.	Effect of driving pressure-guided individualised positive end-expiratory pressure on postoperative atelectasis in patients with morbid obesity: study protocol of a randomised controlled trial.
	BMJ Open.2025 Mar 06;15(3):e091217.doi:10.1136/bmjopen-2024-091217
	Ren, Yawen (Y);Sun, Yong T (YT);Zhang, Peipei (P);Chen, Lina (L);Liu, Peng (P);Zhou, Zheng (Z);Wang, Yuelan (Y);

10.	The effect of ursodeoxycholic acid in dissolving gallstones formed after laparoscopic sleeve gastrectomy: retrospective cohort study.
	Langenbecks Arch Surg.2025 Mar 07;410(1):91.doi:10.1007/s00423-025-03656-1
	Buyuker, Fatih (F);Sermet, Medeni (M);Ozsoy, Mehmet Sait (MS);Tosun, Salih (S);Ekinci, Özgür (Ö);Baysal, Hakan (H);Alimoglu, Orhan (O);

11.	Anticryptosporidial action mechanisms of Launaea spinosa extracts in Cryptosporidium parvum experimentally infected mice in relation to its UHPLC-MS metabolite profile and biochemometric tools.
	PLoS One.2025 Mar 03;20(3):e0317497.doi:10.1371/journal.pone.0317497
	Elghonemy, Mai M (MM);Sharaf El-Din, Mohamed G (MG);Aboelsoued, Dina (D);Abdelhameed, Mohamed F (MF);El-Saied, Mohamed A (MA);Toaleb, Nagwa I (NI);Farag, Mohamed A (MA);Elshamy, Abdelsamed I (AI);Elgamal, Abdelbaset M (AM);

12.

Statin Therapy is Associated With Lower Risk of Mortality Among Liver Transplant Candidates With Metabolic Dysfunction-associated Steatohepatitis

J Clin Exp Hepatol.?2025 Mar-Apr;15(2):102427.?doi: 10.1016/j.jceh.2024.102427.Epub 2024 Oct 16.

Katherine M Cooper?1,?Ami K Patel?1,?Christopher A Zammitti?1,?Ellen Murchie?1,?Alessandro Colletta?1?2,?Deepika Devuni?1?2

13.

The pleiotropic effects of glucagon-like peptide-1 receptor agonists in patients with metabolic dysfunction-associated steatohepatitis: a review for gastroenterologists

Expert Opin Investig Drugs.?2025 Feb 27.?doi: 10.1080/13543784.2025.2473062.Online ahead of print.

Naim Alkhouri?1,?Michael Charlton?2,?Meagan Gray?3,?Mazen Noureddin?4

14.

Impact of Helicobacter pylori Eradication on Clinical and Laboratory Parameters in Non-alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Curr Med Sci.?2025 Feb 25.?doi: 10.1007/s11596-025-00001-x.?Online ahead of print.

Fouad Jaber?1,?Saqr Alsakarneh?2,?Azizullah Beran?3,?Tala Alsharaeh?4,?Ahmed-Jordan Salahat?4,?Abdelrahman Abdelshafi?5,?Islam Mohamed?6,?Willie Johnson?7,?Khaled Elfert?8,?Mohammad Jaber?9,?Mohammad Almeqdadi?10,?Mohamed Ahmed?11,?Hassan Ghoz?12,?Wendell K Clarkston?11?13,?John H Helzberg?11?13

15.

Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis

Curr Diab Rep.?2025 Feb 18;25(1):23.?doi: 10.1007/s11892-025-01579-1.

Marina W Takawy?1,?Manal F Abdelmalek?2

16.

The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B

Liver Int.?2025 Mar;45(3):e70042.?doi: 10.1111/liv.70042.

Lesley A Patmore?1,?Kirsi van Eekhout?2,?Özgür M Koc?3,?Robert J de Knegt?1,?Harry L A Janssen?1?4,?Willem P Brouwer?1,?Matthijs Kramer?3?5,?Pieter Honkoop?6,?Joep de Bruijne?7,?Greet J Boland?8,?Douwe F Postma?9,?Hans Blokzijl?10,?Robert A de Man?1,?R Bart Takkenberg?2,?Milan J Sonneveld?1

17.

The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease

Hepatol Int.?2025 Feb 27.?doi: 10.1007/s12072-024-10774-3.?Online ahead of print.

Mohammed Eslam?1,?Jian-Gao Fan?2,?Ming-Lung Yu?3,?Vincent Wai-Sun Wong?4,?Ian Homer Cua?5,?Chun-Jen Liu?6,?Tawesak Tanwandee?7,?Rino Gani?8,?Wai-Kay Seto?9?10,?Shahinul Alam?11,?Dan Yock Young?12,?Saeed Hamid?13,?Ming-Hua Zheng?14,?Takumi Kawaguchi?15,?Wah-Kheong Chan?16,?Diana Payawal?17,?Soek-Siam Tan?18,?George Boon-Bee Goh?19?20,?Simone I Strasser?21,?Hang Dao Viet?22,?Jia-Horng Kao?23,?Won Kim?24,?Seung Up Kim?25,?Shelley E Keating?26,?Yusuf Yilmaz?27,?Lubna Kamani?28,?Chia-Chi Wang?29,?Yasser Fouad?30,?Zaigham Abbas?31,?Sombat Treeprasertsuk?32,?Kessarin Thanapirom?32,?Mamun Al Mahtab?33,?Undram Lkhagvaa?34,?Oidov Baatarkhuu?35,?Ashok Kumar Choudhury?36,?Catherine A M Stedman?37,?Abhijit Chowdhury?38,?A Kadir Dokmeci?39,?Fu-Sheng Wang?40,?Han-Chieh Lin?41,?Jee-Fu Huang?42,?Jess Howell?43?44?45?46,?Jidong Jia?47,?Mohamed Alboraie?48,?Stuart K Roberts?49,?Masato Yoneda?50,?Hasmik Ghazinian?51,?Aram Mirijanyan?51,?Yuemin Nan?52,?Cosmas Rinaldi Adithya Lesmana?53,?Leon A Adams?54,?Gamal Shiha?55,?Manoj Kumar?56,?Necati Örmeci?57,?Lai Wei?58,?George Lau?59?60,?Masao Omata?61?62,?Shiv K Sarin?63,?Jacob George?64

18.	Prevalence, Incidence, and Metabolic Characteristics of Young Adults with Type 2 Diabetes Mellitus in South Korea (2010-2020).
	Diabetes Metab J.2025 Mar 01;49(2):172-182.doi:10.4093/dmj.2024.0826
	Kim, Ji Yoon (JY);Lee, Jiyoon (J);Moon, Joon Ho (JH);Park, Se Eun (SE);Ko, Seung-Hyun (SH);Choi, Sung Hee (SH);Kim, Nam Hoon (NH);

19.	Association of occupational noise exposure and shift work with non-alcoholic fatty liver disease: a cross-sectional study of male workers in the Chinese automobile manufacturing industry.
	BMJ Open.2025 Mar 12;15(3):e085753.doi:10.1136/bmjopen-2024-085753
	Zhang, Jinwei (J);Zhang, Yuxia (Y);Qiu, Cong Xi (CX);Zeng, Wenfeng (W);Ruan, Yanmei (Y);Gao, Yunxia (Y);Ma, Weiyu (W);Wu, Kangyong (K);Zhang, Jingwen (J);Cui, Jiaxin (J);Ye, Cuiping (C);Liang, Jiabin (J);Wang, Zhi (Z);

20.	Acceptability and perceptions of a 12-week telehealth exercise programme with dietary advice to increase plant-based protein in people with non-alcoholic fatty liver disease: a programme evaluation using mixed methods.
	BMJ Open.2025 Mar 12;15(3):e086604.doi:10.1136/bmjopen-2024-086604
	Freer, Christine L (CL);George, Elena S (ES);Tan, Sze-Yen (SY);Abbott, Gavin (G);Paris, Tonya (T);Daly, Robin M (RM);

21.	Risk, determinants, and persistence of long-COVID in a population-based cohort study in Catalonia.
	BMC Med.2025 Mar 14;23(1):140.doi:10.1186/s12916-025-03974-7
	Kogevinas, Manolis (M);Karachaliou, Marianna (M);Espinosa, Ana (A);Iraola-Guzmán, Susana (S);Castaño-Vinyals, Gemma (G);Delgado-Ortiz, Laura (L);Farré, Xavier (X);Blay, Natàlia (N);Pearce, Neil (N);de Basea, Magda Bosch (MB);Nogués, Eva Alonso (EA);Dobaño, Carlota (C);Moncunill, Gemma (G);de Cid, Rafael (R);Garcia-Aymerich, Judith (J);

22.	Obstetric and neonatal outcomes of extremely obese pregnant women after late preterm gestation.
	J Matern Fetal Neonatal Med.2025 Feb 27;38(1):2470416.doi:10.1080/14767058.2025.2470416
	Kallubhavi Choodinatha, Harshitha (H);Im, Hyun Joon (HJ);Lee, Jin (J);Lee, Min Jung (MJ);Choi, Bo Young (BY);Kim, Hyeon Ji (HJ);Park, Jee Yoon (JY);

23.	Weight-adjusted waist circumference index with hepatic steatosis and fibrosis in adult females: a cross-sectional, nationally representative study (NHANES 2017-2020).
	BMC Gastroenterol.2025 Mar 05;25(1):137.doi:10.1186/s12876-025-03706-4
	Lian, Yu-E (YE);Wang, Yixuan (Y);Yang, Yinyin (Y);Chen, Jiayu (J);

24.

NAFLD vs MASLD (metabolic dysfunction associated steatotic liver disease) - why the need for a change of nomenclature?

J Clin Endocrinol Metab.?2025 Feb 19:dgaf094.?doi: 10.1210/clinem/dgaf094.Online ahead of print.

Amalia Gastaldelli?1,?Philip N Newsome?2

25.

An exploratory analysis of glucagon-like peptide-1 (GLP-1) agonists and biosimilars: A literature review

Diabetes Obes Metab.?2025 Mar;27(3):1113-1122.?doi: 10.1111/dom.16110.Epub 2024 Dec 9.

Jimmy Wen?1,?Adam Razick?2,?Christiane How-Volkman?1,?Ethan Bernstein?1,?Denise Nadora?1,?Alina Truong?1,?Daniel Razick?1,?Muzammil Akhtar?1,?Muhammad Karabala?1,?Eldo Frezza?1

26.

Multi-Modal Diagnostic Imaging of Metabolic Dysfunction-Associated Steatotic Liver Disease: Non-invasive Analyses by Photoacoustic Ultrasound and MRI

Am J Pathol.?2025 Feb 13:S0002-9440(25)00048-3.?doi: 10.1016/j.ajpath.2025.01.012.Online ahead of print.

Alissa Keegan?1,?Gayathri Malamal?2,?Yichien Lee?1,?Kyle Korolowicz?1,?Blythe D Shepard?3,?Carolyn M Ecelbarger?4,?Mariana Moya Rubiano?1,?Maria Laura Avantaggiati?1,?Moshe Levi?5,?Laurie Rich?2,?Massimo Alfano?6,?Avi Rosenberg?7,?Stanley Fricke?8,?Chris Albanese?9,?Jithin Jose?10,?Olga Rodriguez?11

27.

Food Insecurity Is Increasing and Is More Common Among Persons with Chronic Liver Disease

Dig Dis Sci.?2025 Feb 21.?doi: 10.1007/s10620-025-08928-w.?Online ahead of print.

Cindy W Leung?1,?Elliot B Tapper?2

28.

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021

JHEP Rep.?2024 Nov 14;7(3):101271.?doi: 10.1016/j.jhepr.2024.101271.?eCollection 2025 Mar.

Gong Feng?1?2,?Giovanni Targher?3?4,?Christopher D Byrne?5,?Yusuf Yilmaz?6?7,?Vincent Wai-Sun Wong?8,?Cosmas Rinaldi Adithya Lesmana?9?10?11,?Leon A Adams?12?13,?Jerome Boursier?14?15,?George Papatheodoridis?16,?Mohamed El-Kassas?17?18,?Nahum Méndez-Sánchez?19?20,?Silvia Sookoian?21?22?23,?Laurent Castera?24,?Wah-Kheong Chan?25,?Feng Ye?2,?Sombat Treeprasertsuk?26,?Helena Cortez-Pinto?27,?Hon Ho Yu?28,?Won Kim?29?30,?Manuel Romero-Gómez?31,?Atsushi Nakajima?32,?Khin Maung Win?33,?Seung Up Kim?34,?Adriaan G Holleboom?35,?Giada Sebastiani?36,?Ponsiano Ocama?37,?John D Ryan?38,?Monica Lup?or-Platon?39,?Hasmik Ghazinyan?40,?Mamun Al-Mahtab?41,?Saeed Hamid?42,?Nilanka Perera?43,?Khalid A Alswat?44,?Qiuwei Pan?45,?Michelle T Long?46,?Vasily Isakov?47,?Man Mi?1,?Marco Arrese?48,?Arun J Sanyal?49,?Shiv Kumar Sarin?50,?Nathalie Carvalho Leite?51,?Luca Valenti?52?53,?Philip N Newsome?54,?Hannes Hagström?55?56,?Salvatore Petta?57,?Hannele Yki-Järvinen?58?59,?Jörn M Schattenberg?60,?Marlen I Castellanos Fernández?61,?Isabelle A Leclercq?62,?Gulnara Aghayeva?63,?Abdel-Naser Elzouki?64?65?66,?Ali Tumi?67,?Ala I Sharara?68,?Asma Labidi?69,?Faisal M Sanai?70,?Khaled Matar?71,?Maen Al-Mattooq?72,?Maisam Waid Akroush?73,?Mustapha Benazzouz?74,?Nabil Debzi?75,?Maryam Alkhatry?76,?Salma Barakat?77,?Said A Al-Busafi?78,?John Rwegasha?79,?Wah Yang?80,?Agyei Adwoa?81?82,?Christopher Kenneth Opio?83,?Mohammadjavad Sotoudeheian?84?85,?Yu Jun Wong?86?87,?Jacob George?88,?Ming-Hua Zheng?89?90

29.

A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH

J Hepatol.?2025 Feb 10:S0168-8278(25)00069-8.?doi: 10.1016/j.jhep.2025.01.032.Online ahead of print.

Stephen A Harrison?1,?Naim Alkhouri?2,?Grisell Ortiz-Lasanta?3,?Madhavi Rudraraju?4,?Dean Tai?5,?Katy Wack?6,?Amrik Shah?7,?Robin Besuyen?8,?Hilde H Steineger?8,?David A Fraser?9,?Arun J Sanyal?10;?ICONA Study Investigators

30.

Rencofilstat Treatment Improves Liver Function in MASH With Advanced Fibrosis as Quantified by HepQuant DuO

Liver Int.?2025 Mar;45(3):e70036.?doi: 10.1111/liv.70036.

Stephen A Harrison?1,?Patrick Mayo?2,?Todd Hobbs?2,?Caroline Zhao?2,?Carlos Canizares?2,?Robert Foster?2,?Michael P McRae?3,?Steve M Helmke?4,?Gregory T Everson?4

31.

Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective

Aliment Pharmacol Ther.?2025 Feb 18.?doi: 10.1111/apt.70020.?Online ahead of print.

Zobair M Younossi?1?2,?Homie Razavi?3,?Michael Sherman?4?5,?Alina M Allen?6,?Quentin M Anstee?7?8,?Kenneth Cusi?9,?Scott L Friedman?10,?Eric Lawitz?11,?Jeffrey V Lazarus?12?13?14,?Detlef Schuppan?15?16,?Manuel Romero-Gómez?17,?Jörn M Schattenberg?18,?Miriam B Vos?19,?Vincent Wai-Sun Wong?20,?Vlad Ratziu?21,?Marcus Hompesch?22,?Arun J Sanyal?23,?Rohit Loomba?24

32.

How improvements in US FDA regulatory process and procedures led to the drug approval for first ever treatment of a common liver disease

Acta Pharmacol Sin.?2025 Mar;46(3):515-524.?doi: 10.1038/s41401-024-01396-4.Epub 2024 Nov 7.

Brian E Harvey?1

33.

Validation of the Chronic Liver Disease Questionnaire for MASH (CLDQ-MASH)

JHEP Rep.?2024 Nov 16;7(3):101276.?doi: 10.1016/j.jhepr.2024.101276.?eCollection 2025 Mar.

Zobair M Younossi?1,?Maria Stepanova?1,?Issah Younossi?1,?Andrei Racila?1

34.	SOX9 Overexpression Ameliorates Metabolic Dysfunction-associated Steatohepatitis Through Activation of the AMPK Pathway.
	J Clin Transl Hepatol.2024 Dec 20;13(3):189-199.doi:10.14218/JCTH.2024.00197
	Deng, Juan (J);Ding, Kai (K);Liu, Shuqing (S);Chen, Fei (F);Huang, Ru (R);Xu, Bonan (B);Zhang, Xin (X);Xie, Weifen (W);

35.	Impact of blood lead and manganese levels on metabolic dysfunction-associated steatotic liver disease prevalence: insights from NHANES (2017-2020).
	BMC Gastroenterol.2025 Mar 11;25(1):160.doi:10.1186/s12876-025-03731-3
	Guo, Wenying (W);Weng, Ting (T);Song, Yufei (Y);

36.	Dapagliflozin attenuates metabolic dysfunction-associated steatotic liver disease by inhibiting lipid accumulation, inflammation and liver fibrosis.
	BMC Pharmacol Toxicol.2025 Mar 12;26(1):59.doi:10.1186/s40360-025-00898-z
	Fan, Xingyu (X);Wang, Yueyue (Y);Wang, Yue (Y);Duan, Hao (H);Du, Yijun (Y);Pan, Tianrong (T);Zhong, Xing (X);

37.	Does integration matter? an international cross-sectional study on the relationship between perceived public health and primary care integration and COVID-19 vaccination rates.
	PLoS One.2025 Feb 21;20(2):e0317970.doi:10.1371/journal.pone.0317970
	Sodhi, Sumeet (S);Chamali, Rifka (R);Praveen, Devarsetty (D);Sharma, Manushi (M);Garcia Dieguez, Marcelo (M);Mash, Robert (R);Goodyear-Smith, Felicity (F);Ponka, David (D);

38.	Risk factors for diabetic foot ulcer in diabetic patients at the Tehran diabetes clinic: a case-control study.
	J Diabetes Metab Disord.2025 Feb 20;24(1):70.doi:10.1007/s40200-025-01582-z
	Bagheri, Seyedeh Elaheh (SE);Khalagi, Kazem (K);Nasli-Esfahani, Ensieh (E);Amini, Mohammadreza (M);Rambod, Kamelia (K);Razi, Farideh (F);Mostafavi, Farideh (F);Nazari, Saeed Hashemi (SH);Ostovar, Afshin (A);

39.	Diagnostic Journey and Therapeutic Intervention of a Type-1 Interferonopathy in a Newborn (P6-8.002).
	Neurology.2024 Apr 09;102(7_supplement_1):6859.doi:10.1212/WNL.0000000000208137
	Varnet, Marie (M);Kayani, Saima (S);Wang, Cynthia (C);

40.	Serum uric acid as a biomarker for metabolic dysfunction-associated steatotic liver disease: insights from ultrasound elastography in a Chinese cohort.
	BMC Gastroenterol.2025 Feb 20;25(1):94.doi:10.1186/s12876-025-03666-9
	Chang, Zhe (Z);Liu, Zhe (Z);

41.	Multifaceted environmental factors linked to metabolic dysfunction-associated fatty liver disease: an environment-wide association study.
	BMC Public Health.2025 Feb 20;25(1):709.doi:10.1186/s12889-025-21930-1
	Dong, Rui (R);Tian, Ting (T);Ming, Chen (C);Zhang, Ru (R);Xue, Hong (H);Luo, Zhenghan (Z);Shen, Chao (C);Ni, Yunlong (Y);Shao, Jianguo (J);Wang, Jie (J);

42.	Intra and inter-organ communication through extracellular vesicles in obesity: functional role of obesesomes and steatosomes.
	J Transl Med.2025 Feb 20;23(1):207.doi:10.1186/s12967-024-06024-7
	Lago-Baameiro, N (N);Camino, T (T);Vazquez-Durán, A (A);Sueiro, A (A);Couto, I (I);Santos, F (F);Baltar, J (J);Falcón-Pérez, J M (JM);Pardo, M (M);

43.	Analyzing MASLD interventional clinical trial registration based on the ClinicalTrials.gov database.
	BMC Gastroenterol.2025 Mar 07;25(1):148.doi:10.1186/s12876-025-03732-2
	Du, Hui (H);Huang, Jihan (J);Wang, Youhua (Y);Wang, Chunyan (C);Wang, Yiqun (Y);Hou, Luming (L);Li, Yali (Y);Li, Ying (Y);Su, Qianmin (Q);

44.	The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice.
	BMC Endocr Disord.2025 Mar 10;25(1):63.doi:10.1186/s12902-025-01879-3
	Di Vincenzo, Angelo (A);Granzotto, Marnie (M);Crescenzi, Marika (M);Fioretto, Paola (P);Vettor, Roberto (R);Rossato, Marco (M);

45.	Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study.
	Open Med (Wars).2025 Feb 19;20(1):20251154.doi:10.1515/med-2025-1154
	Li, Yu (Y);Lv, Xiaodan (X);Lin, Jianing (J);Li, Shiquan (S);Lin, Guangfu (G);Huang, Zhixi (Z);Chen, Deyi (D);Han, Lichun (L);Zhan, Lingling (L);Lv, Xiaoping (X);

46.	Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): statistical analysis plan for a randomised controlled trial.
	Trials.2025 Feb 19;26(1):58.doi:10.1186/s13063-025-08761-6
	Ahmed, Norin (N);Dehbi, Hakim-Moulay (HM);Freemantle, Nick (N);Best, Jonathan (J);Nash, Philip S (PS);Ruffle, James K (JK);Doig, David (D);Werring, David J (DJ);

47.	The association between the dietary index for gut microbiota and non-alcoholic fatty liver disease and liver fibrosis: evidence from NHANES 2017-2020.
	BMC Gastroenterol.2025 Mar 12;25(1):163.doi:10.1186/s12876-025-03756-8
	Zheng, Ce (C);Qi, Zeming (Z);Chen, Rui (R);Liao, Zhixiong (Z);Xie, Lanfeng (L);Zhang, Fumang (F);

48.	Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancer.
	BMC Cancer.2025 Mar 12;25(1):441.doi:10.1186/s12885-025-13829-2
	Yang, Mingli (M);Nebozhyn, Michael V (MV);Schell, Michael J (MJ);Gandhi, Nishant (N);Pflieger, Lance (L);Loboda, Andrey (A);Pledger, W Jack (WJ);Soundararajan, Ramani (R);Maurin, Michelle (M);Wang, Heiman (H);Silva, Jetsen Rodriguez (JR);Alden, Ashley (A);Coppola, Domenico (D);Elliott, Andrew (A);Sledge, George (G);Khushman, Moh'd (M);Lou, Emil (E);Goel, Sanjay (S);Yeatman, Timothy J (TJ);

49.	Fundamentals of telehealth: A learning compendium for residents.
	AEM Educ Train.2025 Feb 14;9(1):e11059.doi:10.1002/aet2.11059
	Wang, Lulu (L);Chandra, Shruti (S);Nash, Christopher J (CJ);Fabiano, Anthony Tony (AT);Hou, Peter C (PC);Whitehead, David C (DC);Kolkin, Alexander (A);Tomovic, Milos (M);Hayden, Emily M (EM);

50.	Comparative analysis of metabolic and bariatric surgery outcomes and complications in patients under and over 50 years of age.
	Langenbecks Arch Surg.2025 Feb 14;410(1):71.doi:10.1007/s00423-025-03644-5
	Rezapanah, Alireza (A);Ebrahimi, Parisa (P);Sherafati, Hamzeh (H);Dalili, Amin (A);Jangjoo, Ali (A);Emadzadeh, Maryam (M);Parhizgar, Pooyan (P);

51.	The effect of empagliflozin on non-alcoholic fatty liver disease-related parameters in patients with type 2 diabetes mellitus: a randomized controlled trial.
	BMC Endocr Disord.2025 Feb 26;25(1):52.doi:10.1186/s12902-025-01882-8
	Shojaei, Fatemeh (F);Erfanifar, Azam (A);Kalbasi, Saeid (S);Nikpour, Shahriar (S);Gachkar, Latif (L);

52.	Optimization of regions of interest sampling strategies for proton density fat-fraction MRI of hepatic steatosis before liver transplantation in ex vivo livers.
	Heliyon.2024 Nov 19;11(4):e40146.doi:10.1016/j.heliyon.2024.e40146
	Chen, Gen (G);Tang, Hao (H);Yang, Yang (Y);Zhou, Lifen (L);Wang, Qiuxia (Q);Hu, Daoyu (D);Li, Zhen (Z);

53.	The impact of sleeve gastrectomy on pulmonary function tests and physical activity one-year after surgery.
	BMC Surg.2025 Feb 28;25(1):83.doi:10.1186/s12893-025-02804-0
	Abbasi, Mohammadmahdi (M);Mohammadzadeh, Narjes (N);Shahi, Mohammad Hossein Pourgharib (MHP);Soroush, AhmadReza (A);Eslamian, Reza (R);Mir, Ali (A);Elyasinia, Fezzeh (F);Talebpour, Mohammad (M);Najjari, Khosrow (K);Mahmoudabadi, Hossein Zabihi (HZ);Pourfaraji, Seyed Morteza (SM);

54.	Comprehensive evaluation of diabetes subtypes in a European cohort reveals stronger differences of lifestyle, education and psychosocial parameters compared to metabolic or inflammatory factors.
	Cardiovasc Diabetol.2025 Feb 28;24(1):99.doi:10.1186/s12933-025-02660-5
	Rohmann, Nathalie (N);Epe, Johannes (J);Geisler, Corinna (C);Schlicht, Kristina (K);Türk, Kathrin (K);Hartmann, Katharina (K);Kruse, Lucy (L);Koppenhagen, Julia (J);Kohestani, Ahmad Yusuf (AY);Adam, Tanja (T);Bang, Corinna (C);Franke, Andre (A);Schulte, Dominik M (DM);Hollstein, Tim (T);Laudes, Matthias (M);

55.	The associations between evening eating and quality of energy and macronutrients and obesity: the National Health and Nutrition Examination Survey (NHANES), 2003-2016.
	Nutr J.2025 Feb 28;24(1):33.doi:10.1186/s12937-025-01094-9
	Hou, Wanying (W);Wang, Weiqi (W);Sun, Changhao (C);

56.	Quantitative CT and COPD: cluster analysis reveals five distinct subtypes with varying exacerbation risks.
	BMC Pulm Med.2025 Feb 26;25(1):92.doi:10.1186/s12890-025-03562-8
	Peng, Chusheng (C);Chen, Zizheng (Z);Zhou, Haobin (H);Dai, Chaoyue (C);Yuan, Haolei (H);Gao, Yuan (Y);Wang, Fengyan (F);Liang, Zhenyu (Z);

57.	Deep proteome profiling of metabolic dysfunction-associated steatotic liver disease.
	Commun Med (Lond).2025 Mar 03;5(1):56.doi:10.1038/s43856-025-00780-3
	Boel, Felix (F);Akimov, Vyacheslav (V);Teuchler, Mathias (M);Terkelsen, Mike Krogh (MK);Wernberg, Charlotte Wilhelmina (CW);Larsen, Frederik Tibert (FT);Hallenborg, Philip (P);Lauridsen, Mette Munk (MM);Krag, Aleksander (A);Mandrup, Susanne (S);Ravnskjær, Kim (K);Blagoev, Blagoy (B);

58.	Psoriatic arthritis in Jordan: a cross-sectional study of disease characteristics, patient-reported outcomes, and disease activity.
	BMC Rheumatol.2025 Feb 17;9(1):16.doi:10.1186/s41927-025-00468-0
	Alnaimat, Fatima (F);Alawneh, Khaldoon (K);AbuHelal, Ayman (A);Hamdan, Omar (O);Alelaimat, Almothana (A);Al Mashaleh, Manal (M);Burqan, Ausaylah (A);Rababah, Wala (W);Rababah, Rabaa (R);Adwan, Marwan (M);

59.	Implementation of the healthy heart tool- an algorithm with potential cardiometabolic health benefits in persons with severe mental illness.
	BMC Psychiatry.2025 Feb 25;25(1):172.doi:10.1186/s12888-025-06578-w
	Lund-Stenvold, Elisabeth Haug (EH);Ringen, Petter A (PA);Andreassen, Ole A (OA);Gaarden, Torfinn L (TL);Hartberg, Cecilie B (CB);Johnsen, Erik (E);Myklatun, Silje (S);Osnes, Kåre (K);Sørensen, Kjetil (K);Vaaler, Arne (A);Tonstad, Serena (S);Engh, John A (JA);Høye, Anne (A);

60.	Multi-pathway targeted therapy of MASH-HCC using miR-22.
	Cell Biosci.2025 Feb 14;15(1):20.doi:10.1186/s13578-025-01352-7
	Hu, Ying (Y);Setayesh, Tahereh (T);Wei, Dongguang (D);Testerman, Trenton (T);Ji, Yutong (Y);Wan, Yu-Jui Yvonne (YY);

61.	IFN-?-mediated inhibition of JAK/STAT signaling via nano-scutellarin treatment is an efficient strategy for ameliorating liver fibrosis.
	J Transl Med.2025 Feb 17;23(1):195.doi:10.1186/s12967-025-06155-5
	Wang, Ting (T);Liu, Bangguo (B);Huang, Juan (J);Zhao, Qixin (Q);Shen, Hongping (H);Bi, Tao (T);Liu, Zengjin (Z);Dai, Yong (Y);Sun, Qin (Q);

62.	"Attitude is the fifth delay": perspectives of obstetric near-miss survivors and health care professionals on continuity and coordination of maternal care.
	BMC Health Serv Res.2025 Feb 19;25(1):276.doi:10.1186/s12913-025-12341-4
	Mulongo, Samuel M (SM);Kaura, Doreen (D);Mash, Bob (B);

63.	Demographic, epidemiological and clinical profile of patients with post-COVID syndrome followed at a teaching hospital in Brazil.
	Braz J Infect Dis.2025 Feb 19;29(2):104509.doi:10.1016/j.bjid.2025.104509
	Melo, João Paulo Borges de (JPB);Silva, Alex Eduardo da (AED);Yamamoto, Leandro Resende (LR);Ferreira, Taciana Fernandes Araújo (TFA);Luvizutto, Gustavo José (GJ);Neves, Fernando Freitas (FF);Santos, Kelly Cristina (KC);Batista, Roger Lopes (RL);Santos, Isabel Cunha (IC);Schiavoni, Francielle (F);Silva-Vergara, Mario León (ML);

64.	[Idiopathic Intracranial Hypertension: Clinical-Epidemiological Profile and Factors Associated with Visual Outcome].
	Rev Med Chil.2025 Feb 03;152(11):1120-1129.doi:10.4067/s0034-98872024001101120
	Urquiola Cortés, Natalia (N);Fernández Salgado, Verónica (V);Luco Franzoy, Christian (C);Trigo Daroni, Cecilia (C);Romero, Nathaly Amaya (NA);Klagges Troncoso, Jorge (J);

65.	The long-term impact of hypertriglyceridemia-waist phenotype on major adverse cardiovascular events in elderly patients with OSA.
	Sleep Breath.2025 Mar 08;29(1):125.doi:10.1007/s11325-025-03257-8
	Li, Tian-Jiao (TJ);Feng, Qiao (Q);Nie, Ting-Yu (TY);Gao, Ying-Hui (YH);Yang, Ling (L);Zhao, Li-Bo (LB);Xue, Xin (X);Zhao, Zhe (Z);Cai, Wei-Meng (WM);Rui, Dong (D);Han, Ji-Ming (JM);Liu, Lin (L);

66.	Special Diets and Nutrient Intakes in Morbidly Obese US Adults in Comparison to the 2020-2025 Dietary Guidelines for Americans.
	Nutr J.2025 Mar 08;24(1):37.doi:10.1186/s12937-025-01088-7
	Storz, Maximilian Andreas (MA);Stübing, Frieda (F);Huber, Roman (R);

67.	The effects of smoking, alcohol consumption, obesity, and physical inactivity on healthcare costs: a longitudinal cohort study.
	BMC Public Health.2025 Mar 05;25(1):873.doi:10.1186/s12889-025-22133-4
	Kim, Younhee (Y);

68.	Ultra-processed foods and coronary artery disease severity: a cross-sectional study of at-risk normal-weight and overweight patients undergoing elective angiography.
	J Health Popul Nutr.2025 Mar 05;44(1):63.doi:10.1186/s41043-025-00796-4
	Ghorbani, Zeinab (Z);Dashti, Fatemeh (F);Grafenauer, Sara (S);Arami, Samira (S);Mahdavi-Roshan, Marjan (M);Salari, Arsalan (A);

69.	The complex role of glycine N-methyltransferase in metabolism-a review.
	Mol Biol Rep.2025 Mar 01;52(1):271.doi:10.1007/s11033-025-10374-w
	Suzauddula, Md (M);Islam, Md Numan (MN);Ahmed, Tanvir (T);

70.	The effect of chitosan supplementation on liver function, hepatic steatosis predictors, and metabolic indicators in adults with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled, clinical trial.
	J Health Popul Nutr.2025 Mar 01;44(1):60.doi:10.1186/s41043-025-00797-3
	Mohsenpoor, Mohammad Ali (MA);Parastouei, Karim (K);Taghdir, Maryam (M);Akbarzadeh, Marzieh (M);Abbaszadeh, Sepideh (S);Abyazi Heris, Mohammad Ali (MA);Mansouri Rad, Mohammad Reza (MR);Jafari, Mohammad Amin (MA);Borzooei, Ronak (R);

71.	Cannabis Use and Self-Reported Bothersome Symptoms in People with HIV.
	Cannabis.2025 Feb 01;8(1):177-190.doi:10.26828/cannabis/2025/000269
	Wrona, Aleksandra (A);Justice, Amy C (AC);Tate, Janet P (JP);Rentsch, Christopher T (CT);Gordon, Kirsha S (KS);Kidwai-Khan, Farah (F);Silverberg, Michael J (MJ);Satre, Derek D (DD);Marconi, Vincent C (VC);Ingle, Suzanne M (SM);Sterne, Jonathan A C (JAC);Cavassini, Matthias (M);Bryant, Kendall (K);McGinnis, Kathleen A (KA);

72.	Weight Loss and Therapeutic Metabolic Effects of Tetrahydrocannabivarin (THCV)-Infused Mucoadhesive Strips.
	Cannabis.2025 Feb 01;8(1):109-120.doi:10.26828/cannabis/2024/000206
	Smith, Gregory L (GL);

73.	Association of prebiotic/probiotic intake with MASLD: evidence from NHANES and randomized controlled trials in the context of prediction, prevention, and a personalized medicine framework.
	EPMA J.2025 Jan 29;16(1):183-197.doi:10.1007/s13167-025-00398-4
	Wang, Senlin (S);Zhang, Ruimin (R);Guo, Peisen (P);Yang, Huawu (H);Liu, Yanjun (Y);Zhu, Hongmei (H);

74.	Association of fatty liver with serum gamma-glutamyltransferase and uric acid in obese children in a tertiary care centre.
	BMC Pediatr.2025 Feb 26;25(1):144.doi:10.1186/s12887-025-05484-0
	Maduri, Vidanapathirana Dinesha (VD);Eresha, Jasinge (J);Dulani, Samaranayake (S);Pujitha, Wickramasinghe (W);

75.	Exploring the hepatic-ophthalmic axis through immune modulation and cellular dynamics in diabetic retinopathy and non-alcoholic fatty liver disease.
	Hum Genomics.2025 Feb 26;19(1):19.doi:10.1186/s40246-025-00730-z
	Zhang, Shuyan (S);Wu, Jiajun (J);Wang, Leilei (L);Zhang, Cheng (C);Zhang, Yinjian (Y);Feng, Yibin (Y);

76.	Hyperosmotic Stress Promotes the Nuclear Translocation of TFEB in Tubular Epithelial Cells Depending on Intracellular Ca Signals via TRPML Channels.
	Cell Mol Bioeng.2025 Jan 21;18(1):39-52.doi:10.1007/s12195-024-00839-6
	Miyano, Takashi (T);Suzuki, Atsushi (A);Konta, Hisaaki (H);Sakamoto, Naoya (N);

77.	Two faces of the same coin non alcoholic fatty liver disease; with and without diabetes: Comparative clinico pathological analysis: A cross sectional observational study.
	J Family Med Prim Care.2025 Jan 13;14(1):56-61.doi:10.4103/jfmpc.jfmpc_1208_23
	Mushfiq, Syed (S);Yatoo, Ghulam Nabi (GN);Mir, Bilal Ahmad (BA);Rasool, Zubaida (Z);

78.	Gut Microbiota and Genetic Polymorphisms Appear to Drive Disease Expression of Nonalcoholic Fatty Liver Disease in Lean Individuals.
	J Clin Exp Hepatol.2025 Jan 13;15(3):102503.doi:10.1016/j.jceh.2025.102503
	Anirvan, Prajna (P);Khan, Zaiba H (ZH);Bhuyan, Pallavi (P);Dixit, Sujata (S);Dash, Rishikesh (R);Mishra, Priyanka (P);Venugopal, Giriprasad (G);Balachander, Gowri M (GM);Bharali, Pankaj (P);Gogoi, Mrinal (M);Panigrahi, Manas K (MK);Ranjit, Manoranjan (M);Ramadass, Balamurugan (B);Singh, Shivaram P (SP);

79.	Dietary Inflammatory index and its association with fatty liver disease: a study in obese and non-obese populations.
	BMC Gastroenterol.2025 Feb 21;25(1):102.doi:10.1186/s12876-024-03585-1
	Fu, Wei (W);Zhao, Junlong (J);Cheng, GuoBin (G);Xu, Liang-Bi (LB);Lyu, Linya (L);Ding, Yao (Y);

80.	Human spindle-shaped urine-derived stem cell exosomes alleviate severe fatty liver ischemia-reperfusion injury by inhibiting ferroptosis via GPX4.
	Stem Cell Res Ther.2025 Feb 21;16(1):81.doi:10.1186/s13287-025-04202-y
	Shi, Shangheng (S);Zhu, Cunle (C);Shi, Shangxuan (S);Li, Xinqiang (X);Muhammad, Imran (I);Xu, Qingguo (Q);Li, Xinwei (X);Zhao, Ziyin (Z);Liu, Huan (H);Fu, Guangming (G);Song, Meiying (M);Huang, Xijian (X);Wang, Feng (F);Cai, Jinzhen (J);

81.	Effect of Laparoscopic Sleeve Gastrectomy on Hypothyroidism in Patients with Morbid Obesity: A one-year follow-up Prospective Cohort Study.
	Iran J Pathol.2025 Jan 10;20(1):133-137.doi:10.30699/ijp.2024.2026732.3290
	Malekpour Alamdari, Nasser (N);Ansari, Iman (I);Azizi Nadian, Mohammad Ali (MA);Seyyedi, Mahdiyeh Sadat (MS);Abbasi, Maryam (M);

82.	Associations between Chinese Visceral Adiposity Index and the Risk of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Large Cross-sectional Study.
	Iran J Med Sci.2025 Jan 01;50(1):11-21.doi:10.30476/ijms.2024.100818.3335
	Liu, Hui (H);Deng, Mingming (M);Luo, Gang (G);Chen, Jie (J);

83.	Nurse-led discharge versus consulting surgeon-led discharge for patients who underwent laparoscopic surgeries: an evaluation of follow-up outcome, readmission frequencies, cost of care, and satisfaction of patients.
	BMC Nurs.2025 Feb 26;24(1):218.doi:10.1186/s12912-025-02805-7
	Yang, Bing (B);Luo, Xiaotang (X);Wang, Peiwei (P);Pan, Pengfei (P);Lin, Peishan (P);Zhao, Wenjie (W);

84.	The effect of cholecystectomy for symptomatic gall stone disease on hepatic steatosis using transabdominal ultrasonography: An observational prospective study.
	Turk J Surg.2024 Dec 27;40(4):320-327.doi:10.47717/turkjsurg.2024.6593
	Dhakaria, Umang (U);Kumar Bansiwal, Rajesh (R);Kavita Khemchand, Agrawal (A);Sharma, Rajeev (R);Singh, Mandeep (M);Kaur, Narinder (N);Gupta, Seema (S);

85.	Unveiling the benefits of Vitamin D3 with SGLT-2 inhibitors for hypertensive obese obstructive sleep apnea patients.
	J Transl Med.2025 Mar 07;23(1):296.doi:10.1186/s12967-025-06312-w
	Loh, Huai Heng (HH);Tay, Siow Phing (SP);Koa, Ai Jiun (AJ);Yong, Mei Ching (MC);Said, Asri (A);Chai, Chee Shee (CS);Abdul Malik, Natasya Marliana (NM);Su, Anselm Ting (AT);Tang, Bonnie Bao Chee (BBC);Tan, Florence Hui Sieng (FHS);Sukor, Norlela (N);

86.	Sugarcane leaf disease classification using deep neural network approach.
	BMC Plant Biol.2025 Mar 04;25(1):282.doi:10.1186/s12870-025-06289-0
	Srinivasan, Saravanan (S);Prabin, S M (SM);Mathivanan, Sandeep Kumar (SK);Rajadurai, Hariharan (H);Kulandaivelu, Suresh (S);Shah, Mohd Asif (MA);

87.	Exploring the role of self-led debriefings within simulation-based education: time to challenge the status quo?
	Adv Simul (Lond).2025 Mar 11;10(1):9.doi:10.1186/s41077-025-00342-6
	Kumar, Prashant (P);Harrison, Neil Malcolm (NM);McAleer, Katy (K);Khan, Ibraaheem (I);Somerville, Susan Geraldine (SG);

88.	Utility and cost-effectiveness of LiverMultiScan for MASLD diagnosis: a real-world multi-national randomised clinical trial.
	Commun Med (Lond).2025 Mar 18;5(1):74.doi:10.1038/s43856-025-00796-9
	Shumbayawonda, Elizabeth (E);French, Marika (M);Carolan, Jane Elizabeth (JE);Beyer, Cayden (C);Lorgelly, Paula (P);Tonev, Dimitar (D);Banerjee, Rajarshi (R);Miller, Michael H (MH);Byrne, Christopher D (CD);Patel, Janisha (J);Ajaz, Saima (S);Agarwal, Kosh (K);Backhus, Johanna (J);Coenraad, Minneke J (MJ);Schaapman, Jelte J (JJ);Fraser, Andrew (A);Castelo Branco, Miguel (M);Barclay, Stephen (S);Dollinger, Matthias M (MM);Cuthbertson, Daniel J (DJ);Forton, Daniel (D);Lamb, Hildo J (HJ);

89.	Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: a 15.7-year cohort study.
	BMC Gastroenterol.2025 Feb 11;25(1):75.doi:10.1186/s12876-025-03661-0
	Liang, Yebei (Y);Ye, Xiaoqi (X);Pan, Min (M);Chen, Yijun (Y);Yuan, Yeqing (Y);Luo, Li (L);

90.	Relationship of tea consumption with hepatic steatosis and fibrosis: findings from a longitudinal RaNCD cohort.
	BMC Nutr.2025 Mar 03;11(1):47.doi:10.1186/s40795-025-01032-2
	Qaisar, Shaimaa A (SA);Moludi, Jalal (J);Shahnazi, Narges (N);Soleimani, Davood (D);Pasdar, Yahya (Y);

91.	Peripartum COVID-19 & hemophagocytic lymphohistiocytosis: a case report.
	Case Rep Perinat Med.2024 Dec 17;13(1):20240033.doi:10.1515/crpm-2024-0033
	Mostajeran, Kathy (K);Rabulinksi, Daniel (D);Khan, Abdul (A);Sher, Nehan (N);Huls, Christopher K (CK);Oh, Chien C (CC);

92.	Deep phenotyping of patients with MASLD upon high-intensity interval training.
	JHEP Rep.2024 Dec 16;7(3):101289.doi:10.1016/j.jhepr.2024.101289
	Houttu, Veera (V);Boulund, Ulrika (U);Troelstra, Marian (M);Csader, Susanne (S);Stols-Gonçalves, Daniela (D);Mak, Anne Linde (AL);Dijk, Anne-Marieke van (AV);Bouts, Julia (J);Winkelmeijer, Maaike (M);Verdoes, Xanthe (X);van den Berg-Faay, Sandra (S);Lek, Donne (D);Ronteltap, Ted (T);de Haan, Ferdinand (F);Jorstad, Harald (H);Männistö, Ville (V);Savonen, Kai (K);Pentikäinen, Heikki (H);Hanhineva, Kati (K);Babu, Ambrin Farizah (AF);Panagiotou, Gianni (G);van Delden, Otto (O);Verheij, Joanne (J);Doukas, Michial (M);Nederveen, Aart (A);Schwab, Ursula (U);Grefhorst, Aldo (A);Nieuwdorp, Max (M);Holleboom, Adriaan Georgius (AG);

93.	Spontaneous hemorrhage in adrenal myelolipoma treated with elective laparoscopic adrenalectomy following selective arterial embolization.
	IJU Case Rep.2024 Dec 15;8(2):114-117.doi:10.1002/iju5.12821
	Ito, Itsuho (I);Takehara, Kosuke (K);Miyazaki, Yuya (Y);Tsuchiyama, Ayaka (A);Mukae, Yuta (Y);Hayakawa, Koichi (K);Sakamoto, Ichiro (I);Irie, Junji (J);Watanabe, Junichi (J);

94.	Context sensitive mindfulness: lessons from graduates of a professional training in South Africa.
	BMC Complement Med Ther.2025 Feb 26;25(1):80.doi:10.1186/s12906-025-04775-4
	Whitesman, Simon (S);Mash, Robert (R);

95.	Metabolic profile of procyanidin A2 by human intestinal microbiota and their antioxidant and hypolipidemic potential in HepG2 cells.
	Eur J Nutr.2025 Mar 08;64(3):113.doi:10.1007/s00394-025-03638-5
	He, Liangqian (L);Yang, Guangmei (G);Li, Tongyun (T);Li, Wu (W);Yang, Ruili (R);

96.	Evaluating Continuous Veno-venous Hemodiafiltration Treatment Effects on Biomarkers and Outcomes in Sepsis-Induced Acute Kidney Injury.
	Iran J Kidney Dis.2025 Feb 25;19(1):20-29.doi:10.52547/kmayqh63
	Gao, Yingying (Y);Wen, Jie (J);Zhao, Feng (F);Zhang, Yanqin (Y);

97.	Nano-chitosan hydrogel alleviates Candida albicans-induced health alterations in Nile tilapia (Oreochromis niloticus): antioxidant response, neuro-behaviors, hepato-renal functions, and histopathological investigation.
	BMC Vet Res.2025 Mar 08;21(1):159.doi:10.1186/s12917-025-04568-4
	Mahboub, Heba H (HH);Rahman, Afaf N Abdel (ANA);Elazab, Sara T (ST);Abdelwarith, Abdelwahab A (AA);Younis, Elsayed M (EM);Shaalan, Mohamed (M);Aziz, Enas K (EK);Sobh, Mohammed S (MS);Yousefi, Morteza (M);Ismail, Sameh H (SH);Davies, Simon J (SJ);Gaballa, Mohamed M S (MMS);

98.	Steatotic Liver Disease Education Enhances Knowledge and Confidence to Adhere to Provider Recommendations in Diverse and Vulnerable Populations.
	Gastro Hep Adv.2024 Nov 20;4(3):100589.doi:10.1016/j.gastha.2024.11.005
	Patel, Shyam (S);Partida, Diana (D);Magee, Catherine (C);Garza Romero, Flor E (FE);Chen, Jennifer Y (JY);Tana, Michelle (M);Khalili, Mandana (M);

99.	Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes.
	Diabetes Metab.2025 Feb 19;51(3):101628.doi:10.1016/j.diabet.2025.101628
	Wang, Qian (Q);Chen, Huiyi (H);Deng, Huiling (H);Zhang, Minyi (M);Hu, Haoyue (H);Ouyang, Haotong (H);Ma, Lien (L);Liu, Ruiyan (R);Sun, Jian (J);Hu, Guifang (G);Wang, Kaifeng (K);

100.	Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression.
	JHEP Rep.2024 Nov 12;7(3):101267.doi:10.1016/j.jhepr.2024.101267
	Laschtowitz, Alena (A);Lindberg, Eric L (EL);Liebhoff, Anna-Maria (AM);Liebig, Laura Anne (LA);Casar, Christian (C);Steinmann, Silja (S);Guillot, Adrien (A);Xu, Jun (J);Schwinge, Dorothee (D);Trauner, Michael (M);Lohse, Ansgar Wilhelm (AW);Bonn, Stefan (S);Hübner, Norbert (N);Schramm, Christoph (C);

101.	Legacy of the Tehran Obesity Treatment Study: Findings from 10 Years Bariatric Surgery Survey.
	Int J Endocrinol Metab.2024 Oct 29;22(4):e151608.doi:10.5812/ijem-151608
	Abiri, Behnaz (B);Heidari Almasi, Minoo (M);Hosseinpanah, Farhad (F);Molavizadeh, Danial (D);Khalaj, Alireza (A);Mahdavi, Maryam (M);Valizadeh, Majid (M);Barzin, Maryam (M);

102.	Prevalence of metabolic syndrome in people living with HIV and its multi-organ damage: a prospective cohort study.
	BMC Infect Dis.2025 Mar 12;25(1):351.doi:10.1186/s12879-025-10735-7
	Tang, Jia (J);Chen, Ling (L);Pan, Wei (W);Lu, Lianfeng (L);Liu, Xiaosheng (X);Zhang, Leidan (L);Zheng, Liyuan (L);Song, Xiaojing (X);Guo, Fuping (F);Lv, Wei (W);Cao, Wei (W);Hsieh, Evelyn (E);Li, Taisheng (T);

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

MASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2025 GI Fellow Board of Advisors

Other Resources

Journal Abstracts

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2025 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.

Subscribe